Viewing Study NCT01844505


Ignite Creation Date: 2025-12-25 @ 3:13 AM
Ignite Modification Date: 2026-03-03 @ 8:10 AM
Study NCT ID: NCT01844505
Status: COMPLETED
Last Update Posted: 2025-05-21
First Post: 2013-04-29
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067)
Sponsor:
Organization: